Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 22, 2016
52 pages — Published Sep 22, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Medical Research Council (MRC) is a research organization that provides services to improve human health through medical research. The council offers research across medical sciences services, universities and hospitals, centers and institutes in the UK and Africa. It provides fellowships and studentships programs. MRCs fellowships are personal awards to talented researchers which include clinical research training fellowships, jointly-funded clinical research training, clinician scientist and senior clinical fellowship.

Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company

  
Source:
Document ID
GDPH204321D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Medical Research Council, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
Medical Research Council, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
Medical Research Council, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
Medical Research Council, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
Medical Research Council, Medical Devices Deals, 2010 to YTD 2016101
Medical Research Council, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016113
Medical Research Council, Pharmaceuticals &Healthcare, Deal Details1434
  Partnerships141
    MRC Technology Enters into Co-Development Agreement with IPS-CAS141
    MRC Technology Partners with University of Lausanne151
    MRC Technology Enters into Agreement with Peptinnovate161
    MRC Technology Enters into Co-Development Agreement with Proximagen171
    AstraZeneca Extends Collaboration with MRC Technology181
    MRC Technology Enters into Drug Discovery Agreement with Daiichi Sankyo191
    AstraZeneca Enters Into Drug Discovery Agreement With Medical Research Council202
    MRC Technology Enters Into Co-Development Agreement With Oxford University221
    MRC Technology Enters Into Co-Development Agreement With Boston University231
    MRC Technology Enters Into Agreement With EMBL Enterprise Management For Drug Development241
    MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences251
    MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences261
    Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors271
    MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University281
    MRC Technology Enters Into Second Research Agreement With University of Bristol291
    Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology301
    MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists311
    MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen321
    Medical Research Council, Imperial College, King's College and UCL Form Joint Venture331
    Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture342
    AstraZeneca Enters Into Collaboration With MRC Technology361
    Medical Research Council Enters Into Co-Development With Pharmidex371
  Licensing Agreements381
    Georg-August-University Gottingen Enters into Licensing Agreement with MRC Technology381
    MBM ScienceBridge, Georg-August-University Gottingen, University Medical Center Gottingen and MRC Technology, Enter into Licensing Agreement392
    UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program412
    Cambridge Research Biochemicals Enters Into Licensing Agreement With Medical Research Council431
    Phosphate Therapeutics Enters Into Licensing Agreement With Medical Research Council For PT20442
    MRC Technology Enters Into License Agreement With Genentech461
    Georg-August-Universitat, University of Regensburg Enter Into Licensing Agreement WIth MRC Technology471
Medical Research Council - Key Competitors481
Key Employees491
Locations And Subsidiaries502
  Head Office501
  Other Locations &Subsidiaries502
Appendix521
  Methodology521
  About GlobalData521
  Contact Us521
  Disclaimer521

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 22, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Medical-Research-Council-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-20121>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Medical Research Council - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 22, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Medical-Research-Council-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-20121>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research